ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation

Bai, Bing; Gao, Yan; Wang, Xiao-Xiao; He, Hai-Xia; Ping, Li-Qin; Li, Peng-Fei; Huang, Cheng; Cai, Qi-Chun; Huang, Hui-Qiang中山大学
LEUKEMIA & LYMPHOMADOI: 10.1080/10428194.2020.1808203
4阅读
引用收藏
分享

摘要

At present, autologous stem cell transplantation (ASCT) is considered as an optional consolidation therapy for natural killer/T-cell lymphoma (NKTCL). However, the high-risk patients undergoing ASCT are not clear enough. In this study, 56 patients with advanced staged or relapsed/refractory (R/R) NKTCL undergoing ASCT were reviewed. All patients achieved clinical complete response (CR) before ASCT. The median follow-up time was 36 months (range, 3-192 months). The three-year overall survival (OS) and three-year progression-free survival (PFS) were 70.2% and 56.5%, respectively. The independent prognostic factors for OS included prior testis involvement and pre-ASCT EBV-DNA. Patients without prior testis involvement and negative pre-ASCT EBV-DNA (group A) had better three-year OS (86.3% vs. 47.6%,p < .001) than the rest patients (group B). In conclusion, our study suggests that testis involvement and elevated EBV-DNA might be strong adverse prognostic factors for NKTCL. Patients without the above risk factors are more likely to benefit from ASCT.

学科与关键词

关键词
Autologous stem cell transplantationEpstein-Barr virushigh risknatural killerT-cell lymphomatestis involvement
相关
加载中…
  • CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
    Yang, Jing; Li, Pengfei; Piao, Yingshi; Liu, Xindi; Wei, Liqiang; Sang, Wei*; Zhang, Luo*; Wang, Liang*Frontiers in Immunology, 2022, 13: 829366.被引 1
  • Low absolute CD4+ T cell counts in peripheral blood: an independent predictor of inferior survival in natural killer/T-cell lymphoma-a retrospective cohort study
    Zeng, Ruifang; Zhu, Wenzhuo; Jiang, Li; Zhu, Xi; Gao, Yan; Xia, Yi; Bai, Bing; Shikama, Naoto; Janetos, Timothy M.; Dalia, Samir; Alpdogan, Onder; Wang, Xiaoxiao; Zhu, Lingling*; Li, Pengfei*Annals of Translational Medicine, 2022, 10(20): 1119.
  • The Prognostic Value of Dynamic Change of NK-Cell Counts in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Huan, Chen; Zheng, Zhongxin; Wei, Yongqiang; Guo, Xutao; Wei, Qi; Feng, Ru; Wei, Xiaolei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
查看全部 →

发表信息

论文状态
公开发表
期刊
LEUKEMIA & LYMPHOMA
DOI
10.1080/10428194.2020.1808203
语言
ENGLISH
成果收录
SCIE

作者

  • B

    Bai, Bing (第一作者)

    sun yat sen univ

  • G

    Gao, Yan

    sun yat sen univ

查看全部 9 位作者收起作者
  • W

    Wang, Xiao-Xiao

    sun yat sen univ

  • H

    He, Hai-Xia

    sun yat sen univ

  • P

    Ping, Li-Qin

    sun yat sen univ

  • L

    Li, Peng-Fei

    sun yat sen univ

  • H

    Huang, Cheng

    sun yat sen univ

  • C

    Cai, Qi-Chun

  • H

    Huang, Hui-Qiang

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417